Current landscape and perspective of oncolytic viruses and their combination therapies

por Su, Yinghan, Su, Changqing, Qin, Lunxiu
Publicado 2022

Therapeutic strategy with artificially-designed i-lncRNA targeting multiple oncogenic microRNAs exhibits effective antitumor activity in diffuse large B-cell lymphoma

por Su, Yinghan, Sun, Bin, Lin, Xuejing, Zhao, Xinying, Ji, Weidan, He, Miaoxia, Qian, Haihua, Song, Xianmin, Yang, Jianmin, Wang, Jianmin, Chen, Jie
Publicado 2016

Sulfatase 1 (hSulf-1) reverses basic fibroblast growth factor-stimulated signaling and inhibits growth of hepatocellular carcinoma in animal model

por Xu, Gaoya, Ji, Weidan, Su, Yinghan, Xu, Yang, Yan, Yan, Shen, Shuwen, Li, Xiaoya, Sun, Bin, Qian, Haihua, Chen, Lei, Fu, Xiaohui, Wu, Mengchao, Su, Changqing
Publicado 2014

Triple-serotype chimeric oncolytic adenovirus exerts multiple synergistic mechanisms against solid tumors

por Su, Yinghan, Li, Jiang, Ji, Weidan, Wang, Gang, Fang, Lin, Zhang, Qin, Ang, Lin, Zhao, Min, Sen, Yuan, Chen, Lei, Zheng, Junnian, Su, Changqing, Qin, Lunxiu
Publicado 2022

Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma

por Hu, Beiyuan, Zou, Tiantian, Qin, Wei, Shen, Xiaotian, Su, Yinghan, Li, Jianhua, Chen, Yang, Zhang, Ze, Sun, Haoting, Zheng, Yan, Wang, Chao-Qun, Wang, Zhengxin, Li, Tian-En, Wang, Shun, Zhu, Le, Wang, Xufeng, Fu, Yan, Ren, Xudong, Dong, Qiongzhu, Qin, Lun-Xiu
Publicado 2022